Dr. Agarwal's Eye Hospital Limited

Equities

DRAGARWQ6

INE934C01018

Healthcare Facilities & Services

Delayed Bombay S.E. 03:00:43 2024-05-18 am EDT 5-day change 1st Jan Change
3,298 INR 0.00% Intraday chart for Dr. Agarwal's Eye Hospital Limited -4.38% +18.11%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Dr. Agarwal's Eye Hospital Opens New Branch in Tamil Nadu, India MT
Dr. Agarwal's Eye Hospital's Consolidated Net Profit Drops in Fiscal Q4 MT
Dr. Agarwal's Eye Hospital Limited Recommends Final Dividend for the Financial Year 2023-2024 CI
Dr. Agarwal's Eye Hospital Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Dr. Agarwal's Eye Hospital Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Dr. Agarwal's Eye Hospital Opens New Branch in Puducherry, India MT
Dr. Agarwal's Eye Hospital Opens Two New Branches in Tamil Nadu, India MT
Dr. Agarwal's Eye Hospital Begins Operations of New Branch in Pudukkottai, India MT
Dr. Agarwal's Eye Hospital Begins Operations of Tirurvannamali Branch MT
Dr. Agarwal's Eye Hospital Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Dr. Agarwal's Eye Hospital Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before 18 November 2023 CI
Dr. Agarwal's Eye Hospital Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Dr. Agarwal's Eye Hospital Limited Approves Dividend for the Year Ended March 31, 2023 CI
Indian Equities End Lower, Weighed Down by Potential Rate Hikes in US, Worsening Chinese Economy MT
Dr. Agarwal Gets $80 Million from TPG Growth, Temasek MT
Indian eye hospital chain Dr. Agarwal's raises $80 million from TPG, Temasek RE
Dr. Agarwal's Eye Hospital Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Dr. Agarwal's Eye Hospital Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Dr. Agarwal's Eye Hospital Limited acquired Davangere Nethralaya. CI
Dr. Agarwal's Eye Hospital Limited Recommends Final Dividend for the Fiscal Year 2023 CI
Dr. Agarwal's Eye Hospital Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Dr. Agarwal's Eye Hospital Limited Recommends Final Dividend for the Fiscal Year 2023 CI
Dr. Agarwal's Eye Hospital Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Crisil Keeps A- Rating on Dr. Agarwal's Eye Hospital's Term Loan, Cash Credit; Raises Outlook to Positive MT
Dr. Agarwal's Eye Hospital Opens New Branch in Kerala, India MT
Chart Dr. Agarwal's Eye Hospital Limited
More charts
Dr. Agarwal's Eye Hospital Limited an India-based company, which is primarily engaged in providing eye care and related services. The Company provides eye anatomy & treatments, including retina, uvea, cornea, orbit, photocoagulation, vitrectomy, anti VEGF, dry eyes, scleral buckle, pre descemets endothelial keratoplasty (PDEK), refractive surgery and pediatric ophthalmology. It also provides treatment for cataract, glaucoma, squint, diabetic retinopathy, retinal detachment, retinopathy prematurity, macular edema, traumatic cataract, macular hole, posterior subcapsular cataract, rosette cataract and congenital glaucoma. The Company provides its services in various locations in India, including Tamil Nadu, Karnataka, Maharashtra, Kerala, West Bengal, Odisha, Andhra Pradesh, Puducherry, Gujarat, Rajasthan, Madhya Pradesh, and Andaman.
More about the company
  1. Stock Market
  2. Equities
  3. DRAGARWQ6 Stock
  4. News Dr. Agarwal's Eye Hospital Limited
  5. Dr. Agarwal's Eye Hospital's Consolidated Net Profit Drops in Fiscal Q4
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW